Monitor Q4 revenue to see if sequential growth trajectory continues; watch for FDA submission progress on the Alzheimer's diagnostic test and further cash burn rate. The narrowed guidance range suggests management sees limited upside to the full-year outlook.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $3.38entry
- T+1 · 7d ago −2.96%α −2.59% · $3.28
- T+5 · 17h ago −15.98%α −14.28% · $2.84
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Quanterix reported Q3 2026 revenue of $35.0M, up 6.3% sequentially from Q2 but down 13% YoY from $40.2M. The company narrowed its full-year revenue guidance to $142M-$146M (from $142M-$148M) and lowered its year-end cash forecast to ~$70M. Net loss improved to $21.6M from $33.5M a year ago. The sequential growth is a positive sign after a weak Q2, but YoY revenue decline and cash burn remain concerns.
Key Financial Metrics
Key Facts
- Q3 2026 revenue of $34.97M, down 13% YoY from $40.23M
- GAAP net loss of $21.59M, improved from $33.52M loss in Q3 2025
- Adjusted EBITDA loss of $12.17M, slightly wider than $11.89M in Q3 2025
- Full-year 2026 revenue guidance narrowed to $142M-$146M from $142M-$148M
- Year-end cash balance forecast lowered to ~$70M from prior ~$80M
- Cash and marketable securities at $80.7M as of September 30, 2026
- GAAP gross margin 38.6%, down 90 bps YoY; adjusted gross margin 47.4%, up 150 bps YoY
- EPS of -$0.46 vs consensus estimate of -$0.42 (miss)
- Revenue of $34.97M vs consensus estimate of $33.9M (beat)
Financial Impact
Revenue $35.0M vs consensus $33.9M (beat); EPS -$0.46 vs consensus -$0.42 (miss); full-year guidance narrowed to $142M-$146M; cash burn continues with year-end cash forecast lowered to ~$70M
Risk Factors
- Revenue declined 13% YoY despite sequential improvement
- Cash burn continues with year-end cash forecast lowered to ~$70M
- EPS missed consensus estimates
- Adjusted EBITDA loss widened slightly YoY
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001503274-26-000042 |
| Document: qtrx-20261109.htm | 0001503274-26-000042 |
| Document: q3-26earningspresentatio.htm | 0001503274-26-000042 |
| Document: 0001503274-26-000042-index-headers.html | 0001503274-26-000042 |
| Document: 0001503274-26-000042-index.html | 0001503274-26-000042 |
| Document: 0001503274-26-000042.txt | 0001503274-26-000042 |
| 8-K Data (Synthetic) | 0001503274-26-000042 |
Track record
7 reports on QTRX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $3.28 Now $2.84 −13.41% settles Nov 17
- Nov 9, 20267d ago 8-K Bearish 5/10 Viewing Entry $3.38 to $2.84 Now $2.84 +15.98% ▲ +15.98% +14.28% vs SPY
- Aug 10, 202614w ago 8-K Bearish 8/10 Entry $2.42 to $2.92 Now $2.84 −17.36% ▼ −20.66% −20.71% vs SPY
- Jun 17, 202621w ago Institutional Cluster Bullish 5/10 Entry $2.88 to $3.78 Now $2.84 −1.39% ▲ +31.25% +32.29% vs SPY
- Jun 9, 202622w ago 8-K Neutral 3/10 Entry $3.09 to $3.10 Now $2.84 −8.09% ▲ +0.32% −2.09% vs SPY
- May 26, 202624w ago 8-K Neutral 2/10 Entry $2.65 to $3.53 Now $2.84 +7.17% ▲ +33.21% +32.74% vs SPY
- May 8, 202627w ago DEFA14A Neutral 2/10 Entry $2.80 to $2.52 Now $2.84 +1.43% ▼ −10.00% −9.91% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers